Fumarranol, a Rearranged Fumagillin Analogue That Inhibits Angiogenesis in Vivo

Fumarranol, a Rearranged Fumagillin Analogue That Inhibits Angiogenesis in Vivo Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2 Antiparasitic activities of novel, orally available fumagillin analogs Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity Design, synthesis and evaluation of a cellular stable and detectable biotinylated fumagillin probe and investigation of cell permeability of fumagillin and its analogs to endothelial and cancer cells Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol RK-95113, a New Angiogenesis Inhibitor Produced by Aspergillus fumigatus Synthesis of a magnosalin derivative, 4-(3,4,5-trimethoxyphenyl)-6-(2,4,5-trimethoxyphenyl)-2-diethylaminopyrimidine, and the anti-angiogenic and anti-rheumatic effect on mice by oral administration Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes the Akt pathway Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis